ISSN: 0958-1669

Journal Home

Journal Guideline

Current Opinion in Biotechnology Q1 Unclaimed

Elsevier Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Opinion in Biotechnology is a journal indexed in SJR in Biotechnology and Bioengineering with an H index of 214. It has a price of 2100 €. It has an SJR impact factor of 2.17 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2.17.

Current Opinion in Biotechnology focuses its scope in these topics and keywords: design, plant, protein, systems, expression, engineering, bacteria, metabolic, constructionthe, common, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Bioengineering (Q1) Biomedical Engineering (Q1) Biotechnology (Q1)

Price

2100 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

2.17

SJR Impact factor

214

H Index

182

Total Docs (Last Year)

516

Total Docs (3 years)

10828

Total Refs

5107

Total Cites (3 years)

485

Citable Docs (3 years)

10.04

Cites/Doc (2 years)

59.49

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Microbiology Q1
Nature Biomedical Engineering Q1
PLoS Medicine Q1
Nano Today Q1
Small Q1

Compare this journals

Aims and Scope

Best articles by citations

BiotechnologyPaper alert

Public reactions and scientific responses to transgenic cropsCommentary

Fermentation technologies for the production of probiotics with high viability and functionality

Forest tree biotechnology

VEGF and therapeutic opportunities in cardiovascular diseases

Paper alert: Biotechnology

Current and emerging technologies for the study of bacteria in the outdoor air

Light at the end of the tunnel: from genes to function

Implications of sequencing bacterial genomes for pathogenesis and vaccine development

Differences among mechanisms of ribozyme-catalyzed reactions

The past and future of structure databases

Engineering the mouse genome by site-specific recombination

SHOW MORE ARTICLES

Engineered liver for transplantation

Bioprocessing of therapeutic proteins

tRNA-mediated protein engineering

Progress in plant metabolic engineering

Plant biotechnology

Antiangiogenic agents

Plant biotechnology Biochemical engineering

Mammals, plants, bacteria, and soil: common problems and solutions in gene expression and analysis

Structures of redox enzymes

NMR spectroscopy in structure-based drug design

Neutron scattering: good news for biotechnology

Protein technologies and commercial enzymes